ArticleAME case reports2025

Pembrolizumab-induced nonischemic cardiomyopathy: a case report of a rare immune-related adverse event.

Abdul Rasheed Bahar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.